Additional $12M financing led by Elevage Medical Technologies and Jonathan Milner alongside existing investors British Business Bank, and GK Goh -- The funding will accelerate development of eProtein ...

Membrane proteins are the gateway to cells and are involved in many critical functions. Each membrane protein is unique, and their complexity makes it difficult to fit into a standardized expression ...

Following the installation of eProtein Discovery at leading academic institutes across the UK and Europe 1, the expansion ...

Cambridge biotech Nuclera has boosted its Series C round to $87 million after securing a further $12m from a range of backers ...

Escherichia coli remains at the forefront of recombinant protein production, owing to its rapid growth, well-characterised genetics and the ease with which it can be genetically manipulated. The ...

Cambridge biotech Nuclera is on the march globally with its much vaunted benchtop eProtein Discovery system following two ...

A biotech which seeks to accelerate drug discovery by providing easy access to functional proteins through its proprietary platform has extended its total Series C funding to £64.5m.

The purification of proteins and antibodies is a critical process in biotechnology and pharmaceutical industries. Traditional methods often involve single-use materials, leading to high costs and ...

Nuclera’s eProtein Discovery system, which accelerates drug discovery by providing rapid, easy access to functional proteins, ...

Nuclera has expanded its Series C funding round to USD $87 million following a new USD $12 million extension led by Elevage ...

The funding will support further development of eProtein Discovery to enable full-format antibody expression, purification, ...